These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9627116)

  • 1. IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops.
    Barzegar C; Meazza R; Pereno R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boyé D; Doucet C; Taoufik Y; Ritz J; Musselli C; Mishal Z; Jasmin C; Indiveri F; Ferrini S; Azzarone B
    Oncogene; 1998 May; 16(19):2503-12. PubMed ID: 9627116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
    Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
    Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-15/IL-15Ralpha intracellular trafficking in human melanoma cells and signal transduction through the IL-15Ralpha.
    Pereno R; Giron-Michel J; Gaggero A; Cazes E; Meazza R; Monetti M; Monaco E; Mishal Z; Jasmin C; Indiveri F; Ferrini S; Azzarone B
    Oncogene; 2000 Oct; 19(45):5153-62. PubMed ID: 11064452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours.
    García-Vázquez MD; Boyano MD; Cañavate ML; Gardeazabal J; de Galdeano AG; López-Michelena T; Ratón JA; Izu R; Díaz-Ramón JL; Díaz-Pérez JL
    Eur Cytokine Netw; 2000 Dec; 11(4):654-61. PubMed ID: 11125310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells.
    He YG; Mayhew E; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4240-6. PubMed ID: 15557426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.
    Schadendorf D; Möller A; Algermissen B; Worm M; Sticherling M; Czarnetzki BM
    J Immunol; 1993 Sep; 151(5):2667-75. PubMed ID: 8360485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines.
    Sun R; Li AL; Wei HM; Tian ZG
    Cell Res; 2004 Feb; 14(1):67-73. PubMed ID: 15040892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of IL-2 receptors in human melanoma cells.
    Rimoldi D; Salvi S; Hartmann F; Schreyer M; Blum S; Zografos L; Plaisance S; Azzarone B; Carrel S
    Anticancer Res; 1993; 13(3):555-64. PubMed ID: 8317884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL2 triggers a tumor progression process in a melanoma cell line MELP derived from a patient whose metastasis increased in size during IL2/INFalpha biotherapy.
    Han D; Pottin-Clemenceau C; Imro MA; Scudeletti M; Doucet C; Puppo F; Brouty-Boye D; Vedrenne J; Sahraoui Y; Brailly H; Poggi A; Jasmin C; Azzarone B; Indiveri F
    Oncogene; 1996 Mar; 12(5):1015-23. PubMed ID: 8649792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are interleukin-2 and interleukin-15 tumor promoting factors for human non-hematopoietic cells?
    Azzarone B; Pottin-Clemenceau C; Krief P; Rubinstein E; Jasmin C; Scudeletti M; Indiveri F
    Eur Cytokine Netw; 1996; 7(1):27-36. PubMed ID: 8704093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of interleukin 6 receptor alpha chain in interleukin 6 transduced melanoma cells causes selective resistance to interleukin 6 but not to oncostatin M.
    Silvani A; Ferrari G; Paonessa G; Toniatti C; Parmiani G; Colombo MP
    Cancer Res; 1995 May; 55(10):2200-5. PubMed ID: 7743524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides.
    Meazza R; Gaggero A; Neglia F; Basso S; Sforzini S; Pereno R; Azzarone B; Ferrini S
    Eur J Immunol; 1997 May; 27(5):1049-54. PubMed ID: 9174591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.
    Flørenes VA; Lu C; Bhattacharya N; Rak J; Sheehan C; Slingerland JM; Kerbel RS
    Oncogene; 1999 Jan; 18(4):1023-32. PubMed ID: 10023678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice.
    Mrowietz U; Schwenk U; Maune S; Bartels J; Küpper M; Fichtner I; Schröder JM; Schadendorf D
    Br J Cancer; 1999 Mar; 79(7-8):1025-31. PubMed ID: 10098731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis.
    Wittnebel S; Da Rocha S; Giron-Michel J; Jalil A; Opolon P; Escudier B; Validire P; Khawam K; Chouaib S; Azzarone B; Caignard A
    Cancer Res; 2007 Jun; 67(12):5594-9. PubMed ID: 17575122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cells express a functional interleukin-15 receptor.
    Tejman-Yarden N; Zlotnik M; Lewis E; Etzion O; Chaimovitz C; Douvdevani A
    Nephrol Dial Transplant; 2005 Mar; 20(3):516-23. PubMed ID: 15671076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human renal cancer cells express a novel membrane-bound interleukin-15 that induces, in response to the soluble interleukin-15 receptor alpha chain, epithelial-to-mesenchymal transition.
    Khawam K; Giron-Michel J; Gu Y; Perier A; Giuliani M; Caignard A; Devocelle A; Ferrini S; Fabbi M; Charpentier B; Ludwig A; Chouaib S; Azzarone B; Eid P
    Cancer Res; 2009 Feb; 69(4):1561-9. PubMed ID: 19190330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of interleukin 10 and NO release by transplantable melanoma cell lines with regard to their progression.
    Kozłowska K; Zarzeczna M; Cichorek M; Wójcik S
    Neoplasma; 2003; 50(2):85-90. PubMed ID: 12740640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 10 production by human melanoma.
    Sato T; McCue P; Masuoka K; Salwen S; Lattime EC; Mastrangelo MJ; Berd D
    Clin Cancer Res; 1996 Aug; 2(8):1383-90. PubMed ID: 9816311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).
    Asemissen AM; Scheibenbogen C; Letsch A; Hellstrand K; Thorén F; Gehlsen K; Schmittel A; Thiel E; Keilholz U
    Clin Cancer Res; 2005 Jan; 11(1):290-7. PubMed ID: 15671558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.